- Sell-side engagement
- Buyer-side engagement
- Identifying prospective strategic or financial buyers on a global basis
We are industry veterans keenly focused on utilizing deep sector insights and extensive deal-making experience to provide impactful advisory services.
We are committed to providing candid, objective advice that serves the best interests of our clients, not ours.
E: [email protected] | P: 858-245-4905
In parallel to his investment banking and strategic advisory leadership for Cardiff Advisory, Dr. Crean currently serves as a Senior Advisor to Objective Capital's Investment Banking services, and is in leading roles on the Boards of Directors for Histogen, Inc. (Nasdaq: HSTO), Phoenix Molecular Designs, BIOCOM California, and the California Life Sciences Association (CLSA) as Chairman of Development and a member of the Executive Committee. He is also an active life sciences investor where he serves as Managing Director for Equitos, Venture Partner for Suncoast Venture Capital, and a Limited Partner with Mesa Verde Venture Partners.
For his outstanding advisory work, Dr. Crean was recognized by San Diego Business Journal for SD500 Most Influential Business Leaders in 2019-2021, M&A Advisors for the 2019 Investment Banker of the Year, San Diego Business Journal’s 2018 Healthcare Hero, 2017 Thought Leader of the Year and 2017 Advisor of the Year Awards.
Dr. Crean is also active in the non-profit sector where he serves as Chairman of the Board for the Alzheimer’s Association of San Diego/ Imperial Counties, CEO's Against Cancer for the American Cancer Society, and Student Success Programs of the Charter School of San Diego.
Dr. Crean holds a Masters of Business Administration (MBA) Degree with a finance concentration from Pepperdine University Graziadio School of Management. Additionally, he holds a Doctorate of Philosophy (Ph.D.) Degree in Biophysics and a Masters of Science (MS) Degree in Oncology from the State University of New York at Buffalo. Dr. Crean also earned a Bachelor of Science (BS) Degree in Biology/ Pre-Med from Canisius College.
E: [email protected] | P: 503-765-5260
She spent several years in business development for an interactive digital marketing agency, working with industry professionals from the high tech, biomedical and aerospace industries. Prior to these Business Development roles, Charla spent over 15 years of her career focused on connecting industry and academia in the area of Biomedical Engineering, including founding and running a non-profit with this mission, working with over 60 Universities nationwide. She has actively served on the OSU College of Engineering board for Chem, Bio and Environmental Engineering for the past 10 years. Ms. Triplett completed her M.S. in Bioengineering at OSU in 1999.
E: [email protected] | P: 619-985-4616
Our firm is committed to investing its time, talent, and treasure in local and national charities that drive impact in the communities that they serve. A portion of the firm’s profits supports the missions of various leading organizations including: